ACC / WCC 2023
Summaries from ACC.23 Annual Scientific Session & Expo Together With World Congress of Cardiology, held from March 4 – 6, 2023.
Young adult cancer survivors show high incidence of high blood pressure
Presenter: Ericka Miller, BS, BA, of William & Mary College, Williamsburg, VA
High blood pressure is common among cancer survivors and is a leading modifiable risk factor for adverse cardiovascular outcomes in these patients.
Ethnic minority adolescent girls with obesity have higher risk of type 2 diabetes
Presenter: Veronica Njuguna, MD, of Kaiser Permanente, Oakland, CA
Among obese adolescent girls, those who are Black, Latina, or Asian or Pacific Islander have about a 2-fold higher risk of type 2 diabetes mellitus (T2DM).
Adding sotatercept to existing therapy provides a new treatment approach for pulmonary arterial hypertension
Presenter: Marius M. Hoeper, MD, Hannover Medical School, Hannover, Germany
Sotatercept added to existing therapy for pulmonary arterial hypertension induces significant improvements in exercise capacity and significantly reduces the risk of death or worsening of clinical events.
Older, overweight men are more likely to have asymptomatic atrial fibrillation
Presenter: Jessica Mao, MD, Cedars Sinai Medical Center, Los Angeles, CA
Older, overweight men are at higher risk for presenting with asymptomatic atrial fibrillation and, thus, may benefit from targeted atrial fibrillation screening.
Patch-based cardiac rhythm monitoring more accurately detects arrhythmias than multi- electrode system
Presenter: Lohit Garg, MD, University of Pennsylvania, Philadelphia, PA
An ambulatory patch-based cardiac rhythm monitoring system provides more accurate information for determining atrial fibrillation (AFib) than a multi-electrode, wire-based monitoring system.
Long-term continuous cardiac monitoring provides effective arrhythmia diagnoses in Medicare beneficiaries
Presenter: Suneet Mittal, MD, Valley Health System, Ridgewood, NJ
Ambulatory cardiac monitoring using long-term continuous monitoring tools more effectively diag-noses arrhythmias with both lower healthcare utilization and costs compared with other ambulato-ry monitoring systems, according to Medicare beneficiary data.
New ablation technology effectively treats atrial fibrillation
Presenter: Atul Verma, MD, McGill University Health Centre, Montreal, Canada
Pulsed field ablation, a new technology for atrial fibrillation ablation, has been shown to eliminate both persistent and paroxysmal atrial fibrillation for 12 months in up to 80% of patients with adverse event rates below 1%.
Artificial intelligence-assisted echocardiography can help novices screen for heart failure
Presenter: Feiqiong Huang, MD, PhD, National Heart Centre Singapore, Singapore
Artificial intelligence (AI)-assisted point-of-care echocardiography enables laypeople to perform accurate echocardiography screening for heart failure in most cases.
Next-generation Ambulatory ECG Monitor Delivers High-quality Clinical Data
Presenter: Jay H. Alexander, MD, of North Shore University Health System Faculty Practice, Evanston, IL
A lighter, more compliant next-generation ECG monitor may improve both patient and provider experience, with both standard 14-day and extended 30-day wear.
Sensors, Wearables and Remote Monitoring Help Provide Integrated Cardiology Care
Presenter: Ami Bhatt, MD, of Massachusetts General Hospital, Boston, MA
New wearables and remote monitoring in cardiology provide the promise for better integrated care to improve both clinical practice and patients’ quality of life.
Bempedoic Acid Improves Clinical Outcomes in Statin-Intolerant Patients
Presenter: Steven E. Nissen, MD, Cleveland Clinic, Cleveland, OH
The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13% in a large trial of patients who were unable to tolerate statins.